Literature DB >> 10482558

Mutation of neuraminidase cysteine residues yields temperature-sensitive influenza viruses.

C F Basler1, A García-Sastre, P Palese.   

Abstract

The influenza virus neuraminidase (NA) is a tetrameric, virus surface glycoprotein possessing receptor-destroying activity. This enzyme facilitates viral release and is a target of anti-influenza virus drugs. The NA structure has been extensively studied, and the locations of disulfide bonds within the NA monomers have been identified. Because mutation of cysteine residues in other systems has resulted in temperature-sensitive (ts) proteins, we asked whether mutation of cysteine residues in the influenza virus NA would yield ts mutants. The ability to rationally design tight and stable ts mutations could facilitate the creation of efficient helper viruses for influenza virus reverse genetics experiments. We generated a series of cysteine-to-glycine mutants in the influenza A/WSN/33 virus NA. These were assayed for neuraminidase activity in a transient expression system, and active mutants were rescued into infectious virus by using established reverse genetics techniques. Mutation of two cysteines not involved in intrasubunit disulfide bonds, C49 and C146, had modest effects on enzymatic activity and on viral replication. Mutation of two cysteines, C303 and C320, which participate in a single disulfide bond located in the beta5L0,1 loop, produced ts enzymes. Additionally, the C303G and C320G transfectant viruses were found to be attenuated and ts. Because both the C303G and C320G viruses exhibited stable ts phenotypes, they were tested as helper viruses in reverse genetics experiments. Efficiently rescued were an N1 neuraminidase from an avian H5N1 virus, an N2 neuraminidase from a human H3N2 virus, and an N7 neuraminidase from an H7N7 equine virus. Thus, these cysteine-to-glycine NA mutants allow the rescue of a variety of wild-type and mutant NAs into influenza virus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482558      PMCID: PMC112825          DOI: 10.1128/JVI.73.10.8095-8103.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Characterization of temperature sensitive influenza virus mutants defective in neuraminidase.

Authors:  P Palese; K Tobita; M Ueda; R W Compans
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

2.  Structure of the catalytic and antigenic sites in influenza virus neuraminidase.

Authors:  P M Colman; J N Varghese; W G Laver
Journal:  Nature       Date:  1983 May 5-11       Impact factor: 49.962

3.  Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution.

Authors:  J N Varghese; W G Laver; P M Colman
Journal:  Nature       Date:  1983 May 5-11       Impact factor: 49.962

4.  Biosynthesis, intracellular transport and enzymatic activity of an avian influenza A virus neuraminidase: role of unpaired cysteines and individual oligosaccharides.

Authors:  J Hausmann; E Kretzschmar; W Garten; H D Klenk
Journal:  J Gen Virol       Date:  1997-12       Impact factor: 3.891

5.  Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness.

Authors:  K Subbarao; A Klimov; J Katz; H Regnery; W Lim; H Hall; M Perdue; D Swayne; C Bender; J Huang; M Hemphill; T Rowe; M Shaw; X Xu; K Fukuda; N Cox
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

6.  Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice.

Authors:  Y Miyahira; A García-Sastre; D Rodriguez; J R Rodriguez; K Murata; M Tsuji; P Palese; M Esteban; F Zavala; R S Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

7.  Loss of enzyme activity in a site-directed mutant of influenza neuraminidase compared to expressed wild-type protein.

Authors:  M R Lentz; G M Air
Journal:  Virology       Date:  1986-01-15       Impact factor: 3.616

8.  Influenza virus neuraminidase with hemagglutinin activity.

Authors:  W G Laver; P M Colman; R G Webster; V S Hinshaw; G M Air
Journal:  Virology       Date:  1984-09       Impact factor: 3.616

9.  Complete nucleotide sequence of the neuraminidase gene of human influenza virus A/WSN/33.

Authors:  A L Hiti; D P Nayak
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

10.  Identification of defects in the neuraminidase gene of four temperature-sensitive mutants of A/WSN/33 influenza virus.

Authors:  T J Bos; D P Nayak
Journal:  Virology       Date:  1986-10-15       Impact factor: 3.616

View more
  10 in total

1.  Delta(12)-prostaglandin J(2) is a potent inhibitor of influenza A virus replication.

Authors:  F Pica; A T Palamara; A Rossi; A De Marco; C Amici; M G Santoro
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

2.  Molecular characterization of mammalian-adapted Korean-type avian H9N2 virus and evaluation of its virulence in mice.

Authors:  Kuk Jin Park; Min-Suk Song; Eun-Ha Kim; Hyeok-Il Kwon; Yun Hee Baek; Eun-Hye Choi; Su-Jin Park; Se Mi Kim; Young-Il Kim; Won-Suk Choi; Dae-Won Yoo; Chul-Joong Kim; Young Ki Choi
Journal:  J Microbiol       Date:  2015-07-31       Impact factor: 3.422

3.  The short stalk length of highly pathogenic avian influenza H5N1 virus neuraminidase limits transmission of pandemic H1N1 virus in ferrets.

Authors:  Deena Blumenkrantz; Kim L Roberts; Holly Shelton; Samantha Lycett; Wendy S Barclay
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

4.  Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus.

Authors:  Terrence M Tumpey; Adolfo García-Sastre; Andrea Mikulasova; Jeffery K Taubenberger; David E Swayne; Peter Palese; Christopher F Basler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

5.  Activation of tumor antigen-specific cytotoxic T lymphocytes (CTLs) by human dendritic cells infected with an attenuated influenza A virus expressing a CTL epitope derived from the HER-2/neu proto-oncogene.

Authors:  Clay L Efferson; Jeanne Schickli; Byung Kyum Ko; Kouichiro Kawano; Sara Mouzi; Peter Palese; Adolfo García-Sastre; Constantin G Ioannides
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

6.  The influenza virus neuraminidase protein transmembrane and head domains have coevolved.

Authors:  Diogo V da Silva; Johan Nordholm; Dan Dou; Hao Wang; Jeremy S Rossman; Robert Daniels
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

7.  Influenza A viruses balance ER stress with host protein synthesis shutoff.

Authors:  Beryl Mazel-Sanchez; Justyna Iwaszkiewicz; Joao P P Bonifacio; Filo Silva; Chengyue Niu; Shirin Strohmeier; Davide Eletto; Florian Krammer; Gene Tan; Vincent Zoete; Benjamin G Hale; Mirco Schmolke
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-07       Impact factor: 11.205

8.  Are Poultry or Wild Birds the Main Reservoirs for Avian Influenza in Bangladesh?

Authors:  Mohammad Mahmudul Hassan; Md Ahasanul Hoque; Nitish Chandra Debnath; Mat Yamage; Marcel Klaassen
Journal:  Ecohealth       Date:  2017-06-15       Impact factor: 3.184

9.  Host Cell Copper Transporters CTR1 and ATP7A are important for Influenza A virus replication.

Authors:  Jonathan C Rupp; Manon Locatelli; Alexis Grieser; Andrea Ramos; Patricia J Campbell; Hong Yi; John Steel; Jason L Burkhead; Eric Bortz
Journal:  Virol J       Date:  2017-01-23       Impact factor: 4.099

10.  Protein Disulfide Isomerase A3 Regulates Influenza Neuraminidase Activity and Influenza Burden in the Lung.

Authors:  Nicolas Chamberlain; Mona Ruban; Zoe F Mark; Sierra R Bruno; Amit Kumar; Ravishankar Chandrasekaran; Dhemerson Souza De Lima; Danielle Antos; Emily M Nakada; John F Alcorn; Vikas Anathy
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.